Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)

MONDO:0035941

Also known as: B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged, B lymphoblastic leukaemia lymphoma with t(v;11q23); MLL rearranged, B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged

1852 clinical trials for this condition and its sub-types, 8 tagged with B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality (59)

Including sub-types (1852) Tagged with B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) (8)

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 1

Promising new combo targets Hard-to-Treat infant leukemia

Disease control Ongoing

This study tests a new oral drug (revumenib) combined with standard chemotherapy for infants and young children with a specific type of leukemia (KMT2A-rearranged) that has returned or not responded to treatment. The goal is to see if the combination is safe and works better than…

Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC